Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kyburz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|August 1, 1993
T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptidesD Kyburz, P Aichele, D E Speiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Human rheumatoid factor production is dependent on CD40 signaling and autoantigenD Kyburz, M Corr, D C Brinson, et al.
Zeitschrift Fur Rheumatologie|June 29, 2006
[Evidence-based therapy of Raynaud's syndrome]M Distler, J Distler, A Ciurea, et al.
The Journal of Experimental Medicine|May 1, 1992
Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogenyD E Speiser, H Pircher, P S Ohashi, et al.
Annals of the Rheumatic Diseases|March 17, 2006
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational studyL Brulhart, A Ciurea, A Finckh, et al.
Scandinavian Journal of Rheumatology|August 17, 2017
Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive goutB Ankli, D Kyburz, A Hirschmann, et al.
Swiss Medical Weekly|April 12, 2014
Biological agents in monotherapy for the treatment of rheumatoid arthritisC Gabay, P Hasler, D Kyburz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse modelP Aichele, D Kyburz, P S Ohashi, et al.
Rheumatology (Oxford, England)|April 12, 2007
The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritisM Pierer, F Brentano, J Rethage, et al.
Annals of the Rheumatic Diseases|May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?A Finckh, A Ciurea, L Brulhart, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|August 1, 1993
T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptidesD Kyburz, P Aichele, D E Speiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Human rheumatoid factor production is dependent on CD40 signaling and autoantigenD Kyburz, M Corr, D C Brinson, et al.
Zeitschrift Fur Rheumatologie|June 29, 2006
[Evidence-based therapy of Raynaud's syndrome]M Distler, J Distler, A Ciurea, et al.
The Journal of Experimental Medicine|May 1, 1992
Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogenyD E Speiser, H Pircher, P S Ohashi, et al.
Annals of the Rheumatic Diseases|March 17, 2006
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational studyL Brulhart, A Ciurea, A Finckh, et al.
Scandinavian Journal of Rheumatology|August 17, 2017
Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive goutB Ankli, D Kyburz, A Hirschmann, et al.
Swiss Medical Weekly|April 12, 2014
Biological agents in monotherapy for the treatment of rheumatoid arthritisC Gabay, P Hasler, D Kyburz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse modelP Aichele, D Kyburz, P S Ohashi, et al.
Rheumatology (Oxford, England)|April 12, 2007
The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritisM Pierer, F Brentano, J Rethage, et al.
Annals of the Rheumatic Diseases|May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?A Finckh, A Ciurea, L Brulhart, et al.
Pageof 3